The Regions hold back on the heterologous vaccine: “Before the Aifa clarifies”

Some regions have already started, others will do so today, still others are uncertain and awaiting a new indication from Rome, in particular from Aifa. Replacing the second dose of AstraZeneca with that of a messenger RNA vaccine (Moderna or Pfizer) is not proving to be a walk in the park. Rather. The circular from the Ministry of Health confirming the novelty arrived on Friday night, and yesterday, as the hours passed, various questions arose.